DE602004030936D1 - Verfahren in verbindung mit einer hepatitis-b-infektion - Google Patents

Verfahren in verbindung mit einer hepatitis-b-infektion

Info

Publication number
DE602004030936D1
DE602004030936D1 DE602004030936T DE602004030936T DE602004030936D1 DE 602004030936 D1 DE602004030936 D1 DE 602004030936D1 DE 602004030936 T DE602004030936 T DE 602004030936T DE 602004030936 T DE602004030936 T DE 602004030936T DE 602004030936 D1 DE602004030936 D1 DE 602004030936D1
Authority
DE
Germany
Prior art keywords
hepatitis
infection
method associated
individual
pres1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004030936T
Other languages
English (en)
Inventor
Ulla Hellstrom
Staffan Sylvan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HBV Theranostica AB
Original Assignee
HBV Theranostica AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HBV Theranostica AB filed Critical HBV Theranostica AB
Priority claimed from PCT/EP2004/011958 external-priority patent/WO2005050214A2/en
Publication of DE602004030936D1 publication Critical patent/DE602004030936D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
DE602004030936T 2003-11-12 2004-10-22 Verfahren in verbindung mit einer hepatitis-b-infektion Active DE602004030936D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51915203P 2003-11-12 2003-11-12
GBGB0326416.5A GB0326416D0 (en) 2003-11-12 2003-11-12 Methods and means relating to hepatitis B infection
PCT/EP2004/011958 WO2005050214A2 (en) 2003-11-12 2004-10-22 Methods and means relating to hepatitis b infection

Publications (1)

Publication Number Publication Date
DE602004030936D1 true DE602004030936D1 (de) 2011-02-17

Family

ID=29726432

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004030936T Active DE602004030936D1 (de) 2003-11-12 2004-10-22 Verfahren in verbindung mit einer hepatitis-b-infektion

Country Status (5)

Country Link
US (1) US8076085B2 (de)
CN (1) CN1906488A (de)
AT (1) ATE494555T1 (de)
DE (1) DE602004030936D1 (de)
GB (1) GB0326416D0 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100949310B1 (ko) * 2007-11-21 2010-03-23 한국과학기술연구원 세포 영상 기법을 이용한 ｈｂｖ 캡시드 단백질과 표면단백질 간 상호작용 측정 방법과 이를 이용한 ｈｂｖ 증식억제물질의 검색방법
EP2629096A1 (de) * 2012-02-20 2013-08-21 Roche Diagniostics GmbH HBV-Immunkomplexe zur Reaktionsvorhersage und Therapieüberwachung bei chronischen HBV-Patienten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204096A (en) * 1984-03-07 1993-04-20 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US4847080A (en) * 1984-03-07 1989-07-11 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
AU617292B2 (en) 1986-06-20 1991-11-28 Scripps Clinic And Research Foundation T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen
EP0491077A1 (de) 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
JPH08500673A (ja) 1992-08-21 1996-01-23 アボツト・ラボラトリーズ Ｈｃｖ感染固体においてインターフェロン療法の有効性を監視する方法

Also Published As

Publication number Publication date
US20070054264A1 (en) 2007-03-08
GB0326416D0 (en) 2003-12-17
ATE494555T1 (de) 2011-01-15
US8076085B2 (en) 2011-12-13
CN1906488A (zh) 2007-01-31

Similar Documents

Publication Publication Date Title
HK1081207A1 (en) Hbv precore protein capable of forming particles
DE60317659D1 (de) Unterdruckpumpe und verfahren zur erzeugung von unterdruck
DE60210847D1 (de) Verfahren und Vorrichtung zur Erzeugung von verteilten digitalen Unterschriften
DE60226505D1 (de) Verfahren und vorrichtung zur bestimmung von symmetrie in 2d- und 3d-bildern
DE60120523D1 (de) Vorrichtung und Verfahren zur Verwaltung von Lagekennungen, und Lagekennungverarbeitungsverfahren
DK0726758T3 (da) Peptider til inducering af cytotoksiske T-lymfocytreaktioner over for hepaptitis B virus
HRP20231440T1 (hr) Protutijela koja neutraliziraju virus hepatitisa b i njihova upotreba
SG10201806025TA (en) Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen
ATE493659T1 (de) Verfahren zum nachweis von hepatitis-b-virus
DE50109333D1 (de) Verfahren und vorrichtung zur oberflächenbehandlung von objekten
AP2003002734A0 (en) Purification of HBV antigens for use in vaccines.
DE602004024921D1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs
EP1766098A4 (de) Monoklonale kaninchenantikörper gegen hepatitis-b-oberflächenantigene und verfahren zu ihrer verwendung
EP1412538A4 (de) Verfahren zum gleichzeitigen nachweis von hcv-antigenen und hcv-antikörpern
DE602004030936D1 (de) Verfahren in verbindung mit einer hepatitis-b-infektion
DE60123042D1 (de) L-fmau zur behandlung von hepatitis-delta-virus-infizierung
AU2001246331A1 (en) Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
ATE357540T1 (de) Verfahren zur bakterienunterstützten haldenauslaugung von chalkopyrit
WO2005050214A3 (en) Methods and means relating to hepatitis b infection
DE50106557D1 (de) Verfahren zur aufarbeitung von emulsionspolymerisaten
DE69938466D1 (de) Verfahren und vorrichtung zur handhabung von multimedia anrufen
ATE552264T1 (de) Neue oberflächenprotein- (hbsag-) variante des hepatitis b virus
WO2003040341A3 (en) Anti-hepatitis a virus antibodies
DE60328029D1 (de) VERFAHREN ZUR REINIGUNG VON 3-HYDROXYALKANSuURE-COPOLYMER
EA200700017A1 (ru) Способ усиления иммунного ответа на вакцину